1-4 of 4
Michinari Hirata
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 4085: Distribution analysis of S-222611 in brain metastases of HER2-positive breast cancer by quantitative imaging mass spectrometry: prospect for antitumor activity of EGFR/HER2/HER4 kinase inhibitor S-222611 against brain metastases

Yukari Tanaka, Michinari Hirata, Satomi Shinonome, Mitsunobu Matsumoto, Wataru Nogami, Mikinori Torii, Ken-ichi Nezasa, Hidekazu Tanaka
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 4085.
https://doi.org/10.1158/1538-7445.AM2017-4085
Published: 01 July 2017
View article titled, Abstract 4085: Distribution analysis of S-222611 in brain metastases of HER2-positive breast cancer by quantitative imaging mass spectrometry: prospect for antitumor activity of EGFR/HER2/HER4 kinase inhibitor S-222611 against brain metastases
Journal Articles

Abstract 4073: Antitumor activities of EGFR/HER2/HER4 kinase inhibitor S-222611 in the experimental brain metastases of HER2-positive breast cancer

Michinari Hirata, Yukari Tanaka, Satomi Shinonome, Tomomi Yamada, Mikinori Torii, Ken-ichi Nezasa, Hidekazu Tanaka
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 4073.
https://doi.org/10.1158/1538-7445.AM2017-4073
Published: 01 July 2017
View article titled, Abstract 4073: Antitumor activities of EGFR/HER2/HER4 kinase inhibitor S-222611 in the experimental brain metastases of HER2-positive breast cancer
Journal Articles

Abstract #1761: S-222611, a potent, orally active small molecule inhibitor of EGFR and HER2: in vitro kinase inhibition and antitumor activity

Michinari Hirata, Hidekazu Tanaka, Keiji Dohi, Motofumi Iguchi, Tohru Wada, Kenji Matsuo, Masaharu Kume, Naoki Omori, Yukio Tada, Satoshi Orita, Kenji Abe, Akinori Arimura, Yoshiyuki Matsuo, Akira Kato
Journal: Cancer Research
Cancer Res (2009) 69 (9_Supplement): 1761.
Published: 01 May 2009
View article titled, Abstract #1761: S-222611, a potent, orally active small molecule inhibitor of EGFR and HER2: i<em>n vitro</em> kinase inhibition and antitumor activity
Journal Articles

Heparin-Binding EGF-Like Growth Factor Is a Promising Target for Ovarian Cancer Therapy

Shingo Miyamoto, Michinari Hirata, Ayano Yamazaki, Takuya Kageyama, Hidetoshi Hasuwa, Hiroto Mizushima, Yoshihiro Tanaka, Hiroshi Yagi, Kenzo Sonoda, Masahiro Kai, Hideo Kanoh, Hitoo Nakano, Eisuke Mekada
Journal: Cancer Research
Cancer Res (2004) 64 (16): 5720–5727.
https://doi.org/10.1158/0008-5472.CAN-04-0811
Published: 16 August 2004
View article titled, Heparin-Binding EGF-Like Growth Factor Is a Promising Target for Ovarian Cancer Therapy
Open the PDF for Heparin-Binding EGF-Like Growth Factor Is a Promising Target for Ovarian Cancer Therapy in another window
Includes: Supplementary data